Pharmacia Corp. a future biotech powerhouse? Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Pharmacia Corp. a future biotech powerhouse?

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Jack Hartmann who wrote (8)	4/28/2000 10:33:00 PM
From: Jack Hartmann	of 35

New Study Validates Safety Of Pharmacia Corporation's (PHA) Celebrex On Stroke, Heart Attack Issues Recent news reports have associated Vioxx (rofecoxib), a treatment for osteoarthritis and pain, with stroke and heart attacks. It has been suggested that this may be an effect common to COX-2 inhibitor compounds. However, new data reaffirm that this is not the case for Pharmacia Corporation's innovative COX-2 specific inhibitor, Celebrex(R) (celecoxib capsules). *********** Now at $49. Jack

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next